Vera Therapeutics (VERA) Proxy filing summary

Voting matters and shareholder proposals

• Election of three Class II directors to serve until the 2029 annual meeting is proposed, with nominees Michael M. Morrissey, Patrick G. Enright, and James R. Meyers.

• Ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, is recommended.

• Advisory approval of named executive officer compensation is included as a voting item.

• Proxies are authorized to vote on any other business that may properly come before the meeting.

Board of directors and corporate governance

• Board recommends voting for all three director nominees for Class II positions.

Executive compensation and say-on-pay

• Advisory vote on executive compensation is presented for shareholder approval.